Analysts Bullish on CytomX Therapeutics (CTMX) As CTMX Prices $250 Million Offering

On: April 12, 2026, 6:45 pm EDT

URL has been copied successfully!

Share this story:

Previous Post:Genius Sports (GENI) Hits 52-Week Low Following 50% Year-to-Date Decline

Next Post:Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?